Clinical Trial Update: Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with pegylated liposomal doxorubicin and carboplatin in malignant gynecologic tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Malignant Mixed Mullerian Tumor
• Non-epithelial Ovarian Cancer
• Ovarian Cancer
• Uterine Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Pegylated liposomal doxorubicin (pegylated liposomal doxorubicin)

Snippet

Sponsor: AGO Study Group | Conditions: Cancer of the Ovary Treated as 2nd Line Therapy, Muellerian Mixed Tumours | Phase 2 | Status: COMPLETED